Resveratrol is known to improve endothelial function in animals, but little is known about its
effect on human subjects. Metabolic syndrome (MetS) is a cluster of cardiovascular risk …

Introduction There are current trials investigating the effect of resveratrol supplementation on
endothelial function and blood pressures among patients with metabolic syndrome (MetS); …

We perform a systematic review and meta‐analysis of randomized controlled trials (RCTs) to
quantify the effect of resveratrol supplementation on endothelial function. A comprehensive …

Endothelial dysfunction is a surrogate marker of cardiovascular risk. Resveratrol is known to
improve endothelial function in animals, however, clinical trials are limited. We hypothesized …

Epidemiological studies have demonstrated that the Mediterranean diet, which is rich in
resveratrol, is associated with a significantly reduced risk of cardiovascular disease …

Endothelial dysfunction is a major contributing factor to diseases such as atherosclerosis,
diabetes mellitus, obesity, hypertension, acute lung injury, preeclampsia, among others …

BACKGROUND AND AIMS: Flow-mediated dilatation of the brachial artery (FMD) is a
biomarker of endothelial function and cardiovascular health. Impaired FMD is associated …

Vascular metabolic dysfunction presents in various diseases, such as atherosclerosis,
hypertension, and diabetes mellitus. Due to the high prevalence of these diseases, it is …

BACKGROUND Resveratrol, a natural polyphenol, has gained attention in recent years
because of its connection with the health benefits of red wine and its anticancer activity in …

Studies on the effects of the long-term intake of trans-resveratrol on vascular function are
conflicting. In addition, postprandial effects of long-term trans-resveratrol intake on …